Advances in mRNA nanotherapy

A new Nano Today review reports key milestones in mRNA nanotherapy, including the development of TriLink’s CleanCap^® technology, which was used to cap the Pfizer/BioNTech COVID-19 vaccine. Learn how TriLink’s CleanCap^® technology is advancing the development of mRNA nanotherapies.

A long-read sequencing method for assessing mRNA...

Find out how University of Queensland researchers used TriLink’s CleanCap^® mRNA Capping technology and N1-Methylpseudouridine-5'-Triphosphate to develop VAX-seq, a streamlined alternative to current industry standard methods for assessing mRNA vaccine quality.